Related references
Note: Only part of the references are listed.Evaluation of fungal-specific fluorescent labeled echinocandin probes as diagnostic adjuncts
Ayiasha Pratt et al.
MEDICAL MYCOLOGY (2013)
Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring
Michael J. Dolton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period
Michelle R. Ananda-Rajah et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Regulation of Karyopherin α1 and Nuclear Import by Mammalian Target of Rapamycin
Jill A. Fielhaber et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis
P. Campoli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
An Improved Model of the Aspergillus fumigatus CYP51A Protein
M. G. Fraczek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Posaconazole in Human Serum: a Greater Pharmacodynamic Effect than Predicted by the Non-Protein-Bound Serum Concentration
Anders Lignell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Molecular mechanism of Aspergillus fumigatus adherence to host constituents
Donald C. Sheppard
CURRENT OPINION IN MICROBIOLOGY (2011)
Randomized Comparison of Safety and Pharmacokinetics of Caspofungin, Liposomal Amphotericin B, and the Combination of Both in Allogeneic Hematopoietic Stem Cell Recipients
Andreas H. Groll et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Steady-State Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole in Lung Transplant Recipients
John E. Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Intracellular Concentrations of Posaconazole in Different Compartments of Peripheral Blood
Fedja Farowski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Expression, Purification, and Characterization of Aspergillus fumigatus Sterol 14-α Demethylase (CYP51) Isoenzymes A and B
Andrew G. S. Warrilow et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Current therapeutic approaches to fungal infections in immunocompromised hematological patients
Livio Pagano et al.
BLOOD REVIEWS (2010)
Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
Chiung-Kuang Chen et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Azole Drugs Are Imported By Facilitated Diffusion in Candida albicans and Other Pathogenic Fungi
Bryce E. Mansfield et al.
PLOS PATHOGENS (2010)
Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole at Steady State in Healthy Subjects
John E. Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Transcriptional Profiling Identifies a Role for BrlA in the Response to Nitrogen Depletion and for StuA in the Regulation of Secondary Metabolite Clusters in Aspergillus fumigatus
Kwame Twumasi-Boateng et al.
EUKARYOTIC CELL (2009)
Antifungal Therapy for Invasive Fungal Diseases in Allogeneic Stem Cell Transplant Recipients: An Update
Dustin T. Wilson et al.
MYCOPATHOLOGIA (2009)
The innate immune response to Aspergillus fumigatus
Viviane Balloy et al.
MICROBES AND INFECTION (2009)
Recent Advances in Antifungal Prevention and Treatment
Andreas H. Groll et al.
SEMINARS IN HEMATOLOGY (2009)
Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats
Andrew J. Ullmann et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
Oliver A. Cornely et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
Andrew J. Ullmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts
F. Sabatelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Interactions of Aspergillus fumigatus with endothelial cells:: internalization, injury, and stimulation of tissue factor activity
LML Bezerra et al.
BLOOD (2004)
Three-dimensional models of wild-type and mutated forms of cytochrome P450 14α-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding
L Xiao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Posaconazole is a potent inhibitor of sterol 14α-demethylation in yeasts and molds
HK Munayyer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes
WL Hand et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)